TRENTON, NJ – A federal judge has issued a mixed ruling in a contract dispute between drugmaker Sandoz Inc. and retail giant Sam’s West, Inc., the parent company of Sam’s Club, over nearly $2 million in withheld payments tied to generic drug sales.
U.S. District Judge Georgette Castner granted in part and denied in part Sam’s Club’s motion to dismiss Sandoz’s complaint, allowing some claims to proceed while dismissing others. The ruling follows months of filings and arguments surrounding the companies’ decade-long purchasing relationship.
Sandoz, a pharmaceutical manufacturer and distributor, sued Sam’s Club in early 2025, alleging breach of contract after the retailer deducted roughly $1.97 million from payments between December 2018 and 2021. The deductions were attributed to what Sam’s Club described as “Failure to Supply” (FTS) costs—extra expenses incurred when Sandoz allegedly failed to deliver products—and “Shelf-Stock Adjustments” (SSA) tied to post-sale price reductions.
According to court documents, the companies first entered a purchase contract in 2013 establishing discounted pricing and terms for Sandoz’s products, which Sam’s Club pharmacies carried nationwide. The agreement, later extended through 2023, included provisions governing pricing, dispute resolution, and supply obligations.
Sandoz claimed the deductions were improper and violated the contract, arguing that Sam’s Club unilaterally withheld payments without following agreed-upon dispute procedures. Sam’s Club countered that its actions were consistent with the contract’s failure-to-supply and pricing adjustment clauses.
Judge Castner’s memorandum opinion found that while some of Sandoz’s claims were adequately pleaded to survive dismissal—particularly those involving alleged breaches of payment terms—others were insufficient or covered by contractual defenses raised by Sam’s Club. The court also noted that the dispute resolution provisions of the agreement may require further examination as the case moves forward.
The ruling clears the way for limited discovery on the surviving claims, ensuring that the long-running financial and supply dispute between the two companies will continue in federal court.
- Judge grants in part and denies in part Sam’s Club motion to dismiss Sandoz lawsuit
- Drugmaker seeks nearly $2 million in allegedly improper payment deductions
- Case proceeds on key breach-of-contract claims tied to supply and pricing disputes
